As a special tribute, announces various initiatives for the welfare of doctors,
their families and the community.

Mumbai, India, July 1, 2021 (GPN): Sun Pharmaceutical Industries Ltd. today announced the launch of a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community.
Doctors have been working relentlessly through the pandemic putting their lives at risk to safeguard society. To recognise and care for their health & well-being, on the occasion of National Doctors’ Day, Sun Pharma announces the launch of multifaceted initiatives under Sunkalp. These
initiatives will be rolled out in a phased manner.
 Mental health support for doctors & their families
 Webinars for doctors on mental health by experts
 Donation of Covid-19 medicines (phase 2)
 Post Doctorate educational sponsorship (phase 2)
 Educational aid for children of doctors who lost their lives to Covid-19 (phase 2)
Sun Pharma has committed Rs. 100 crores towards these initiatives, which includes donation of Covid-19 medicines to communities at large through local & state government institutions.
For more than a year, doctors have been fighting the pandemic to save lives. Long stressful working hours, witnessing casualties and maintaining distance from loved ones have become normal for them.
These factors can result in stress & exhaustion not only for them but also for their families. To help them cope with the same, Sun Pharma has partnered with Mann Talks to provide doctors and their
families with confidential emotional and psychological care by trained mental health professionals. Further, to educate doctors on mental health issues & enable them to take better self-care, multiple webinars will be held by experts.
Kirti Ganorkar, CEO – India Business, Sun Pharma, said, “Indian healthcare professionals have faced unprecedented challenges during the pandemic, and their determination to fight against all odds inspires us every day. Sunkalp is a tribute to these heroes for their selfless acts of sacrifice and
kindness. Through this initiative, we want to extend our gratitude to them and contribute to strengthening the healthcare ecosystem.”
The pandemic outbreak has affirmed the need for more medical research to meet unforeseen situations. To encourage research, Sun Pharma will sponsor postgraduate medical students for medical & clinical research in various fields. More than 1000 young scholars will receive grants for their
research projects.
To pay homage to doctors who have lost their lives to Covid-19, Sun Pharma is setting up an Education Fund for their children. The company will provide educational grants to the affected families through this fund.
Sun Pharma has launched a website, https://sunpharmasunkalp.com/ that gives more details on the initiatives under Sunkalp.
The Sunkalp initiative is restricted to India.

About Sun Pharmaceutical Industries Limited (CIN – L24230GJ1993PLC019050):
Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical
company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted
by customers and patients in over 100 countries across the world, at affordable prices. Its global presence is
supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory agencies,
coupled with a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through
innovation supported by strong R&D capabilities across multiple R&D centers, with investments of approximately
6-7% of annual revenues in R&D. For further information, please visit www.sunpharma.com & follow us on
Twitter @SunPharma_Live